Scans

Tools

Home

Charts

Watchlist

Products

Thirumalai Chemicals Ltd

TIRUMALCHM

NSE

₹134.74-5.36%19 Oct 2026

Reports

Specialty Chemicals

Thirumalai Chemicals Ltd

TIRUMALCHM

NSE

₹134.74

-5.36%

19 Oct 2026

SOICxStockScans Reports

Ask AI

Specialty Chemicals

Indices

Business Overview: What the company does, in plain English.Growth Catalysts: The forward growth drivers and triggers.Forensic Report: Accounting quality and red flags.Deep Dive Report: In-depth business analysis.

Thirumalai Chemicals began in 1944 as a chemical trading firm and has spent the decades since turning intermediate chemistry into a manufacturing franchise - it now makes 15 products shipped to over 34 countries. The company's recurring approach is to own the process from end to end: it designs its own plants, captures waste heat to power them, and converts by-product streams into saleable chemicals rather than paying to dispose of them.

Business segments

Three engines at different stages - a world-scale commodity-chemical anchor, a food-ingredients platform built on the anchor’s waste streams, and a North American replica under construction - each funded by the cash flows of the one before.

1. Phthalic Anhydride: the cash engine that pays for everything else

TCL is the largest producer of Phthalic Anhydride in the world and runs the largest single reactor, which gives it a cost position that competitors struggle to match.

Scale that sets the global price - the company operates the world’s largest Phthalic Anhydride reactor at its Ranipet plant, and the newer Dahej plant is among the largest single-train plants anywhere; together they make TCL one of the top three manufacturers globally.
Cheaper to run than rivals - specific energy consumption has fallen by 78% over three decades because the exothermic reaction itself is harnessed to produce steam and power, covering 95% of the plant’s total power requirements.
Waste becomes a second product - a proprietary process takes the scrubber solution that would otherwise be an effluent and turns it into high-value Fumaric Acid, so the plant earns revenue from what competitors would pay to treat.
Located where the customers are - over 60% of India’s domestic demand sits within a 250 km radius of the Dahej plant, and the main feedstock supplier is nearby, which keeps freight costs low and delivery times short.
The moat is the reactor’s uptime - the Ranipet reactor has run for more than 400 days without interruption, and that reliability - combined with import terminals on both coasts for raw-material flexibility - makes the company a supplier customers can depend on.

2. Food Ingredients: the margin layer built on the anchor’s waste

TCL is India’s largest Fumaric Acid maker and, with the US plant, will be one of the largest global producers of Malic and Fumaric Acid - and much of the raw material comes from what the Phthalic Anhydride plant would otherwise throw away.

Recovered, not just manufactured - a good portion of the food-ingredient output is recovered from effluents using proprietary technology, and over 85% of solid wastes leave the site as highly pure saleable products.
Sold into regulated, sticky supply chains - the Ranipet plant holds food-grade certifications including FSSC 22000, HACCP, and Halal, which means once a global food or pharma customer qualifies the product, switching suppliers is slow and costly.
Two acids, dozens of end uses - Fumaric Acid goes into tortillas, sourdough breads, fruit juices, and animal feed, while Malic Acid - made via a patented TCL process - is used in confectionery, beverages, and skin-care products, spreading demand across unrelated industries.
The US plant changes the economics - the West Virginia site will house a Food Ingredients plant of over 30,000 tonnes a year right next to the Maleic Anhydride unit, so the energy-surplus petrochemical plant feeds the energy-intensive fine-chemical plant, cutting energy costs by more than 85%.

3. Maleic Anhydride and the US build-out: the growth engine

TCL is replicating its integrated model in West Virginia, where it will be only the second domestic Maleic Anhydride producer in a market that imports over two-thirds of what it consumes.

Bought, not just built - the New Martinsville site is a fully equipped industrial complex with roads, fire systems, power, water, wastewater treatment, rail siding, and a barge port connected to the ocean, so TCL plugged into existing infrastructure instead of building it from scratch.
Built in India, assembled in America - roughly 80% of the plant was constructed as modules at TCL’s SEZ unit in Ranipet and shipped to the US, which cut project costs by nearly 45% compared with what global peers spend on a similar plant.
Feedstock advantage that the incumbent lacks - the sole raw material is n-Butane sourced from the Marcellus-Utica shale region within 70 miles of the site, and regional prices are at least 25% lower than in other markets; the one existing US producer has no backward integration into n-Butane, so its cost structure is higher.
A merchant market that just opened up - two major Maleic Anhydride producers were recently acquired by end-users for their own consumption, which means the merchant market - the part available to outside buyers - has grown just as TCL’s capacity arrives.
Phased commissioning is underway - the first commercial sale of Maleic Anhydride from the US plant was announced on January 2, 2026, and the plant is expected to stabilise through the first half of 2026.

Technology, Engineering and modular plant construction

TCL designs and builds its own chemical plants - and the capability has become an export in its own right, lowering the cost of every new project the group undertakes.

A plant-building division inside a chemical company - the TCL Technology and Engineering unit, set up in 2020 at Ranipet, designs, engineers, and constructs “ready to startup” modular process plants for chemical and petrochemical industries, both for TCL and for external clients.
The US project is the proof - 100% of the plant and machinery for West Virginia was built modularly at this SEZ unit, with modules shipped from mid-2024 and assembly of the modules at TCL-TE over 99% completed as of January 2025.
Patents and process know-how - the group holds 14 patents, including a new process for Malic Acid, and its R&D lab at Ranipet runs a pilot plant for continuous process improvement.

Group structure and partners

TCL operates through a network of subsidiaries that map directly onto its three geographic theatres - India, Southeast Asia, and North America - with a European distribution arm tying the flows together.

India - the listed parent runs the Ranipet complex; wholly owned TCL Intermediates Private Limited operates the Dahej plant; and the TCL Technology and Engineering division builds the modular plants.
Southeast Asia - Cheminvest Pte Ltd in Singapore is the holding entity for Optimistic Organic Sdn Bhd in Malaysia, which runs a Maleic Anhydride plant acquired in 2012; the Malaysian unit is now under strategic review, including possible divestment, after a machinery failure that prolonged a unit outage.
Europe - TCL Global B.V. in the Netherlands distributes products from India and Malaysia to customers from the UK to Turkey, holds REACH registrations, and maintains an EU warehouse for real-time delivery.
North America - TCL INC. and its subsidiary TCL Specialties LLC own the West Virginia project; the site is designed for four phases of investment, with Phase I budgeted at about USD 255 million.
Cross-shareholding - TCL holds 14.38% in Ultramarine and Pigments Limited, and UPL holds 18.23% in TCL; UPL is part of the promoter group.

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Price

Charts

Documents

Edit Ratios

Mkt Cap

Market Capitalization

₹1,609Cr

Close Price

₹133.50

Industry

Specialty Chemicals

Price To Earnings

—

Price To Sales

0.88

Revenue

₹1,832Cr

Rev Gr TTM

Revenue Growth TTM

-5.80%

PAT Gr TTM

PAT Growth TTM

-36.41%

Consolidated

Standalone

Numbers

Percentage

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	542	492	527	555	525	447	523	450	445	416	424	547
Growth YoY Revenue Growth YoY%	-5.2	-3.2	22.2	6.1	-3.1	-9.2	-0.7	-18.9	-15.2	-6.9	-18.9	21.5
Expenses ExpensesCr	527	498	523	524	502	467	508	477	449	431	418	514
Operating Profit Operating ProfitCr	15	-6	4	31	24	-20	15	-27	-4	-15	6	33
OPM OPM%	2.9	-1.2	0.7	5.5	4.5	-4.5	2.8	-5.9	-0.8	-3.6	1.4	6.0
Other Income Other IncomeCr	6	4	4	3	9	0	8	2	8	4	0	3
Interest Expense Interest ExpenseCr	10	12	10	9	10	14	15	18	26	21	24	52
Depreciation DepreciationCr	16	15	17	14	13	16	18	22	23	23	21	23
PBT PBTCr	-4	-29	-19	11	9	-50	-11	-64	-44	-55	-38	-39
Tax TaxCr	2	-6	2	6	4	-8	3	-4	-10	-9	-10	5
PAT PATCr	-6	-23	-20	5	5	-42	-14	-60	-33	-47	-28	-44
Growth YoY PAT Growth YoY%	-117.5	-376.8	-59.4	-52.2	181.5	-82.9	31.3	-1,278.0	-782.6	-10.8	-99.2	27.2
NPM NPM%	-1.1	-4.7	-3.9	0.9	0.9	-9.4	-2.7	-13.3	-7.5	-11.2	-6.6	-8.0
EPS EPS₹	-0.6	-2.2	-2.0	0.5	0.5	-4.1	-1.4	-5.9	-3.1	-3.9	-2.3	-3.6

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	542	492	527	555	525	447	523	450	445	416	424	547
Growth YoY Revenue Growth YoY%	-5.2	-3.2	22.2	6.1	-3.1	-9.2	-0.7	-18.9	-15.2	-6.9	-18.9	21.5
Expenses ExpensesCr	527	498	523	524	502	467	508	477	449	431	418	514
Operating Profit Operating ProfitCr	15	-6	4	31	24	-20	15	-27	-4	-15	6	33
OPM OPM%	2.9	-1.2	0.7	5.5	4.5	-4.5	2.8	-5.9	-0.8	-3.6	1.4	6.0
Other Income Other IncomeCr	6	4	4	3	9	0	8	2	8	4	0	3
Interest Expense Interest ExpenseCr	10	12	10	9	10	14	15	18	26	21	24	52
Depreciation DepreciationCr	16	15	17	14	13	16	18	22	23	23	21	23
PBT PBTCr	-4	-29	-19	11	9	-50	-11	-64	-44	-55	-38	-39
Tax TaxCr	2	-6	2	6	4	-8	3	-4	-10	-9	-10	5
PAT PATCr	-6	-23	-20	5	5	-42	-14	-60	-33	-47	-28	-44
Growth YoY PAT Growth YoY%	-117.5	-376.8	-59.4	-52.2	181.5	-82.9	31.3	-1,278.0	-782.6	-10.8	-99.2	27.2
NPM NPM%	-1.1	-4.7	-3.9	0.9	0.9	-9.4	-2.7	-13.3	-7.5	-11.2	-6.6	-8.0
EPS EPS₹	-0.6	-2.2	-2.0	0.5	0.5	-4.1	-1.4	-5.9	-3.1	-3.9	-2.3	-3.6

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	944	1,028	1,312	1,261	1,085	1,086	1,998	2,132	2,083	2,050	1,736	1,832
Growth Revenue Growth%	-11.9	8.9	27.6	-3.9	-14.0	0.1	84.0	6.7	-2.3	-1.6	-15.3	-5.8
Expenses ExpensesCr	846	871	1,022	1,055	1,007	865	1,557	1,946	2,032	2,001	1,771	1,812
Operating Profit Operating ProfitCr	98	158	290	206	78	221	441	186	51	49	-35	20
OPM OPM%	10.4	15.3	22.1	16.3	7.2	20.3	22.1	8.7	2.5	2.4	-2.0	1.1
Other Income Other IncomeCr	5	4	7	12	21	7	12	30	19	21	11	16
Interest Expense Interest ExpenseCr	23	17	13	12	17	21	20	31	42	49	89	123
Depreciation DepreciationCr	25	36	31	36	44	50	57	56	63	61	88	90
PBT PBTCr	55	109	253	169	38	157	375	129	-35	-41	-202	-177
Tax TaxCr	23	39	83	55	15	39	94	40	4	5	-34	-25
PAT PATCr	32	71	170	114	23	118	281	90	-39	-46	-168	-152
Growth PAT Growth%	334.3	119.8	141.2	-33.4	-79.6	407.9	139.0	-68.1	-143.2	-18.9	-264.2	-36.4
NPM NPM%	3.4	6.9	13.0	9.0	2.1	10.8	14.1	4.2	-1.9	-2.3	-9.7	-8.3
EPS EPS₹	3.1	6.9	1.7	11.1	2.3	11.5	27.5	8.8	-3.8	-4.5	-14.9	-12.9

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	944	1,028	1,312	1,261	1,085	1,086	1,998	2,132	2,083	2,050	1,736	1,832
Growth Revenue Growth%	-11.9	8.9	27.6	-3.9	-14.0	0.1	84.0	6.7	-2.3	-1.6	-15.3	-5.8
Expenses ExpensesCr	846	871	1,022	1,055	1,007	865	1,557	1,946	2,032	2,001	1,771	1,812
Operating Profit Operating ProfitCr	98	158	290	206	78	221	441	186	51	49	-35	20
OPM OPM%	10.4	15.3	22.1	16.3	7.2	20.3	22.1	8.7	2.5	2.4	-2.0	1.1
Other Income Other IncomeCr	5	4	7	12	21	7	12	30	19	21	11	16
Interest Expense Interest ExpenseCr	23	17	13	12	17	21	20	31	42	49	89	123
Depreciation DepreciationCr	25	36	31	36	44	50	57	56	63	61	88	90
PBT PBTCr	55	109	253	169	38	157	375	129	-35	-41	-202	-177
Tax TaxCr	23	39	83	55	15	39	94	40	4	5	-34	-25
PAT PATCr	32	71	170	114	23	118	281	90	-39	-46	-168	-152
Growth PAT Growth%	334.3	119.8	141.2	-33.4	-79.6	407.9	139.0	-68.1	-143.2	-18.9	-264.2	-36.4
NPM NPM%	3.4	6.9	13.0	9.0	2.1	10.8	14.1	4.2	-1.9	-2.3	-9.7	-8.3
EPS EPS₹	3.1	6.9	1.7	11.1	2.3	11.5	27.5	8.8	-3.8	-4.5	-14.9	-12.9

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	10	10	10	10	10	10	10	10	10	10	12
Reserves ReservesCr	208	388	563	658	628	793	1,075	1,182	1,136	1,145	1,552
Current Liabilities Current LiabilitiesCr	251	327	144	328	301	301	555	866	1,029	926	1,297
Non Current Liabilities Non Current LiabilitiesCr	50	61	108	145	261	239	221	303	1,145	1,725	1,876
Total Liabilities Total LiabilitiesCr	520	786	825	1,141	1,200	1,343	1,862	2,360	3,320	3,807	4,737
Current Assets Current AssetsCr	227	370	338	459	499	573	1,031	1,053	1,134	961	797
Non Current Assets Non Current AssetsCr	294	417	487	681	701	770	831	1,308	2,186	2,846	3,940
Total Assets Total AssetsCr	520	786	825	1,141	1,200	1,343	1,862	2,360	3,320	3,807	4,737

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	10	10	10	10	10	10	10	10	10	10	12
Reserves ReservesCr	208	388	563	658	628	793	1,075	1,182	1,136	1,145	1,552
Current Liabilities Current LiabilitiesCr	251	327	144	328	301	301	555	866	1,029	926	1,297
Non Current Liabilities Non Current LiabilitiesCr	50	61	108	145	261	239	221	303	1,145	1,725	1,876
Total Liabilities Total LiabilitiesCr	520	786	825	1,141	1,200	1,343	1,862	2,360	3,320	3,807	4,737
Current Assets Current AssetsCr	227	370	338	459	499	573	1,031	1,053	1,134	961	797
Non Current Assets Non Current AssetsCr	294	417	487	681	701	770	831	1,308	2,186	2,846	3,940
Total Assets Total AssetsCr	520	786	825	1,141	1,200	1,343	1,862	2,360	3,320	3,807	4,737

Consolidated

Standalone

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	126	108	81	234	140	221	402	54	237	-66	-131
Investing Cash Flow Investing Cash FlowCr	-32	-44	-54	-220	-38	-157	-139	-359	-831	-542	-600
Financing Cash Flow Financing Cash FlowCr	-93	-52	-16	16	46	-38	-70	206	643	375	603
Net Cash Flow Net Cash FlowCr	0	12	10	29	148	25	194	-99	49	-233	-128
Free Cash Flow Free Cash FlowCr	98	85	22	41	38	221	402	55	237	-64	-131
CFO To PAT CFO To PAT%	390.9	153.0	47.4	206.0	602.8	187.6	143.1	60.3	-611.1	142.9	77.9
CFO To EBITDA CFO To EBITDA%	128.5	68.6	27.9	113.6	178.9	100.0	91.3	29.1	464.6	-135.0	371.8

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	126	108	81	234	140	221	402	54	237	-66	-131
Investing Cash Flow Investing Cash FlowCr	-32	-44	-54	-220	-38	-157	-139	-359	-831	-542	-600
Financing Cash Flow Financing Cash FlowCr	-93	-52	-16	16	46	-38	-70	206	643	375	603
Net Cash Flow Net Cash FlowCr	0	12	10	29	148	25	194	-99	49	-233	-128
Free Cash Flow Free Cash FlowCr	98	85	22	41	38	221	402	55	237	-64	-131
CFO To PAT CFO To PAT%	390.9	153.0	47.4	206.0	602.8	187.6	143.1	60.3	-611.1	142.9	77.9
CFO To EBITDA CFO To EBITDA%	128.5	68.6	27.9	113.6	178.9	100.0	91.3	29.1	464.6	-135.0	371.8

Consolidated

Standalone

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	184	906	1,749	910	361	875	2,724	1,760	2,397	2,487	1,990	1,609
Price To Earnings Price To Earnings	6.1	12.8	10.3	8.0	15.6	7.4	9.7	19.6
Price To Sales Price To Sales	0.2	0.9	1.3	0.7	0.3	0.8	1.4	0.8	1.1	1.2	1.1	0.9
Price To Book Price To Book	0.8	2.3	3.0	1.4	0.6	1.1	2.5	1.5	2.1	2.1	1.3	1.0
EV To EBITDA EV To EBITDA	2.4	5.7	6.0	4.5	4.2	3.4	5.3	9.3	59.8	80.2	-111.0	181.4
Profitability Ratios Profitability Ratios
GPM GPM%	23.8	27.0	33.9	26.5	20.0	34.2	33.7	19.6	13.0	14.2	11.0	11.0
OPM OPM%	10.4	15.3	22.1	16.3	7.2	20.3	22.1	8.7	2.5	2.4	-2.0	1.1
NPM NPM%	3.4	6.9	13.0	9.0	2.1	10.8	14.1	4.2	-1.9	-2.3	-9.7	-8.3
ROCE ROCE%	27.4	29.4	42.7	24.3	6.7	18.1	31.7	9.4	0.3	0.3	-3.0	-3.0
ROE ROE%	14.7	17.8	29.8	17.0	3.6	14.7	25.9	7.5	-3.4	-4.0	-10.7	-10.7
ROA ROA%	6.2	9.0	20.7	9.9	1.9	8.8	15.1	3.8	-1.2	-1.2	-3.5	-3.5
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	184	906	1,749	910	361	875	2,724	1,760	2,397	2,487	1,990	1,609
Price To Earnings Price To Earnings	6.1	12.8	10.3	8.0	15.6	7.4	9.7	19.6
Price To Sales Price To Sales	0.2	0.9	1.3	0.7	0.3	0.8	1.4	0.8	1.1	1.2	1.1	0.9
Price To Book Price To Book	0.8	2.3	3.0	1.4	0.6	1.1	2.5	1.5	2.1	2.1	1.3	1.0
EV To EBITDA EV To EBITDA	2.4	5.7	6.0	4.5	4.2	3.4	5.3	9.3	59.8	80.2	-111.0	181.4
Profitability Ratios Profitability Ratios
GPM GPM%	23.8	27.0	33.9	26.5	20.0	34.2	33.7	19.6	13.0	14.2	11.0	11.0
OPM OPM%	10.4	15.3	22.1	16.3	7.2	20.3	22.1	8.7	2.5	2.4	-2.0	1.1
NPM NPM%	3.4	6.9	13.0	9.0	2.1	10.8	14.1	4.2	-1.9	-2.3	-9.7	-8.3
ROCE ROCE%	27.4	29.4	42.7	24.3	6.7	18.1	31.7	9.4	0.3	0.3	-3.0	-3.0
ROE ROE%	14.7	17.8	29.8	17.0	3.6	14.7	25.9	7.5	-3.4	-4.0	-10.7	-10.7
ROA ROA%	6.2	9.0	20.7	9.9	1.9	8.8	15.1	3.8	-1.2	-1.2	-3.5	-3.5
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

	JUBLCPL	ROSSARI	PAUSHAKLTD	TIRUMALCHM	INOVSYNTH	PLATIND	VIKRAMTH
Market CapitalizationMkt CapCr	2,711	2,410	1,658	1,609	1,536	1,249	1,192
Close PriceClose₹	1,789.20	435.00	672.40	133.50	165.40	227.49	380.10
IndustryIndustry	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals
Price To EarningsPE	20.86	15.77	35.06			24.78	27.17
Price To SalesPS	1.37	0.91	5.99	0.88	10.51	2.81	8.26
RevenueRevenueCr	1,972	2,661	277	1,832	146	444	144
Revenue Growth TTMRev Gr TTM%	19.9%	19.8%	28.0%	-5.8%	134.9%	9.6%	16.7%
PAT Growth TTMPAT Gr TTM%	22.3%	11.8%	3.9%	-36.4%	66.7%	10.2%	42.3%

	JUBLCPL	ROSSARI	PAUSHAKLTD	TIRUMALCHM	INOVSYNTH	PLATIND	VIKRAMTH
Market CapitalizationMkt CapCr	2,711	2,410	1,658	1,609	1,536	1,249	1,192
Close PriceClose₹	1,789.20	435.00	672.40	133.50	165.40	227.49	380.10
IndustryIndustry	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals
Price To EarningsPE	20.86	15.77	35.06			24.78	27.17
Price To SalesPS	1.37	0.91	5.99	0.88	10.51	2.81	8.26
RevenueRevenueCr	1,972	2,661	277	1,832	146	444	144
Revenue Growth TTMRev Gr TTM%	19.9%	19.8%	28.0%	-5.8%	134.9%	9.6%	16.7%
PAT Growth TTMPAT Gr TTM%	22.3%	11.8%	3.9%	-36.4%	66.7%	10.2%	42.3%

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2026

Jun 26

Result PPT

Transcript

Summary

Mar 26